查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1856651

按产品类型、技术、测试类型、最终用户、应用和分销管道照护现场和快速诊断市场—2025-2032年全球预测

Point of Care & Rapid Diagnostics Market by Product Type, Technology, Test Type, End User, Application, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，照护现场将达到 912.1 亿美元，复合年增长率为 7.31%。

关键市场统计数据
基准年 2024 518.5亿美元
预计年份：2025年 556.1亿美元
预测年份 2032 912.1亿美元
复合年增长率 (%) 7.31%

重点阐述了快速诊断如何分散检测流程，并在护理点重新定义临床决策时间轴。

即时检测和快速诊断正在重塑临床工作流程，使患者能够更方便地获得可操作的检测结果，并加快临床决策週期。试剂化学、小型化分析仪、高效能读数器和资料管理软体的进步，使得在门诊中心、诊所、居家照护机构和医院开展分散式检查成为可能。随着设备操作更加便捷、互联性更强，临床医生能够更早地进行干预，更有效地进行分诊，从而改变患者的诊疗路径和资源分配。

此外，随着相关人员将价值导向的医疗结果置于优先地位，快速、可靠且能提供可操作数据的诊断方法正成为一项切实可行的优先事项。实验室和诊断网路正在努力平衡中心检测和照护现场能力，以在保证品质的同时提高速度。同时，製造商正在投资整合软体和支援服务，以确保互通性并降低现有设备的整体拥有成本。技术进步、不断变化的医疗模式以及对及时结果日益增长的期望，共同创造了一个动态的环境，在这个环境中，临床获益、报销途径和商业性执行必须协调一致才能取得成功。

技术融合、法规演变和医疗服务模式变革导致市场动态发生变化。

多种因素正在改变诊断检测的方式和地点。分子诊断、免疫测量和小型临床化学平台的技术进步，使得在较小的空间内实现更高的分析性能成为可能。同时，资料管理软体正从孤立的资料收集转向整合解决方案，从而促进与电子健康记录和远端医疗平台的互通性。监管机构也在调整审批流程，以更积极地接受新的即时检测（POC​​）技术，如果製造商能够满足品质和验证要求，则可以缩短临床应用的时间。

同时，向门诊病人治疗和家庭监测的转变迫使製造商重新评估外形规格、易用性和通路策略。包括直销、分销商、电商平台和线上零售在内的分销管道正在优化，以触及新的终端用户，并透过增强的服务模式来维持售后支援。随着相关人员的调整，投资于模组化仪器架构、可扩展试剂系统和云端分析的市场新参与企业将占据有利地位，从而在心臟护理、糖尿病管理、感染疾病诊断、肿瘤应用等领域抢占先机。这意味着下一阶段将奖励将硬体、耗材和软体整合到以用户为中心的解决方案中的跨领域整合。

分析近期美国关税措施对诊断生态系内的供应链、筹资策略和创新所产生的累积影响

关税政策的变化为诊断组件、试剂和成品设备的全球供应链带来了显着的摩擦。依赖跨境采购分析仪、读数仪、试剂和关键电子元件的製造商正在调整其供应商组合和生产地点，以降低这种风险。采购团队正致力于供应商多元化和合约弹性，以应对成本波动和物流延误。

此外，关税也影响企业在本地组装和区域製造方面的决策，因为企业需要权衡生产成本上升与供应弹性所带来的效益。医院、诊所和诊断实验室的采购负责人正面临着采购週期延长的问题，因为相关人员希望明确土地购置成本和服务合约的相关事宜。同时，供应商正在加快对自动化和品管的投资，以抵消更高的单位成本并保护利润率，同时又不影响产品性能。

展望未来，那些积极重新思考筹资策略、优先考虑设备设计模组化以使用相容组件、并加强跨分销管道策略伙伴关係的公司，更有可能降低关税带来的风险。同样重要的是，监管机构和医保报销相关人员需要考虑这些商业性应对措施对高影响力领域（例如分子检测和免疫检测）的准入和创新速度的累积影响。

提供可操作的细分洞察，揭示跨产品类型、技术和最终用户环境的需求驱动因素和商业化重点

从产品类型角度来看，耗材、仪器以及软体和服务有着截然不同的需求。耗材（包括试剂和检测套组）强调批间一致性、货架期稳定性以及供应链的连续性；仪器（包括分析仪和读数仪）则优先考虑稳健性、运作和易于维护；而数据管理软体和支援服务则需要具备安全的互通性、强大的分析能力以及可扩展的服务合约。临床化学、血液学、免疫检测和分子诊断领域的技术碎片化导致了检验路径和使用者期望的多样性。

在考虑诸如心臟标记、凝血功能、血糖监测、感染疾病和妊娠/生育力检测等检测类型时，商业化策略必须与临床路径和报销实际情况相符，才能支持临床医生采用这些检测方法。终端用户细分錶明，门诊医疗中心和诊所优先考虑快速週转和便携性，诊断实验室重视吞吐量和集中化，居家医疗环境追求简便性和远程数据集成，而医院则需要集成到復杂的IT生态系统中。以应用为中心的策略，例如心臟护理、血液凝固检验、糖尿病管理、感染疾病诊断、肿瘤学和妊娠检测，必须在分析严谨性和以使用者为中心的设计之间取得平衡。最后，分销管道的选择——直销、分销商、电子商务平台或线上零售——会影响定价、保固模式和售后支持，因此通路策略是市场准入和客户满意度的核心决定因素。

在不同医疗保健系统和市场环境中部署POC解决方案的区域动态和实际考量

美洲地区呈现出集中式实验室网路与门诊病人和家庭环境中即时检测（POC​​）部署不断扩展的多元化格局，这为实现电子健康记录整合和远端监测的技术创造了机会。欧洲、中东和非洲由于报销结构和基础设施成熟度的差异，其技术应用曲线各不相同。一些市场将快速诊断纳入国家筛检和公共卫生倡议，而其他市场则优先考虑实验室整合。亚太地区的成长得益于对分散式医疗路径的投资、慢性病管理计画的增加以及具有竞争力的製造业基础，这些因素正在加速产品在地化进程。

在所有地区，监管协调、报销政策清晰明确以及供应链韧性仍然是成功商业化的关键因素。以本地为导向的培训和支援模式、量身定制的定价策略以及与临床网路的合作将有助于产品的推广应用。此外，与区域交换医疗资讯平台和远端医疗平台的互通性将增强产品的临床价值提案。最终，能够将全球最佳实践与本地执行能力相结合的公司将在美洲、欧洲、中东和非洲以及亚太地区实现显着的市场普及。

竞争格局分析，重点在于影响市场定位的产品系列、服务提案和伙伴关係模式。

在即时检测 (POC) 和快速诊断领域，主要企业正透过整合解决方案脱颖而出，这些解决方案将模组化分析仪与耗材生态系统和云端资料平台结合。产品系列融合了可靠的试剂、灵活的检测套组以及专为运作设计的设备，为诊断实验室和医院系统创造了巨大的价值。同样，投资于资料管理软体和全面支援服务的机构，透过确保连接性、合规性和全生命週期可维护性，降低了部署阻力。

为了加速检验并产生真实世界证据，伙伴关係模式正转向与临床机构和技术提供者的共同开发契约。融合直销、经销商合作和数位化通路的分销策略，能够在维持本地服务能力的同时，扩大市场覆盖范围。竞争优势越来越取决于企业展示成果、降低整体拥有成本、提供一体化售后支援的能力。在效能、卓越服务和互通性决定买家偏好的市场中，那些能够将产品开发与临床医生工作流程相结合，并利用伙伴关係关係提供端到端解决方案的公司，将更具优势。

为行业领导者提供切实可行的、优先排序的建议，以加速采用新技术、保护利润率并确保其营运面向未来。

製造商正优先考虑模组化仪器架构，这种架构便于组件更换和维护，从而降低供应链中断对营运的影响。同时，投资于支援互通性和远距离诊断的资料管理软体将增强临床医生的信心，并支援基于服务的收入模式。从商业性角度来看，将定价和报销策略与临床结果和总医疗成本挂钩，将推动医院网路和门诊管道的采用。

在营运方面，企业应加强多元化采购策略，考虑建立区域製造伙伴关係以减轻关税影响，并实施灵活的库存管理。与临床试验中心进行策略合作，进行早期检验和真实世界证据的生成，将有助于加速支付方参与和临床医师采纳。最后，建构灵活的分销模式，结合直销、精心挑选的经销商和数位化商务，可以在扩大覆盖范围的同时，维持售后服务标准。这些措施的结合将使企业领导者能够在快速技术创新和医疗服务模式不断演变的环境中，最大限度地发挥影响力、保持净利率并保持敏捷性。

严谨的调查方法和资料整合方法产生了可重复的见解和检验的结论。

此研究过程整合了定性和定量证据，以深入了解市场动态。主要资料来源包括对来自医院、诊断实验室、门诊中心和居家照护机构的临床决策者、采购负责人和产品经理进行的结构化访谈。二级资讯来源包括同行评审文献、监管指南和公司资讯披露，以验证技术趋势、检验要求和商业模式。

资料综合分析采用主题分析法，旨在了解通用的采纳障碍和促进因素，同时透过比较案例研究，重点介绍不同地区的成功采纳模式。在整个调查方法中，我们确保结论是基于检验的专家意见和已记录的绩效特征，而非推测性的预测。这种方法优先考虑假设的透明度和已记录的局限性，使读者能够在适当的营运背景下解读我们的研究结果。这种严谨的调查方法能够得出可复製、可操作的见解，并可应用于策略制定、产品开发和商业规划。

总结性观点，概括了决策者在引领照护现场考虑的策略意义和优先事项。

快速诊断生态系统正处于曲折点，技术进步与不断变化的医疗服务模式和政策环境交汇融合。决策者必须优先考虑硬体、耗材和软体的整合，以在供应链和交易动态动态的情况下，提供持续的临床价值并维持营运韧性。同样重要的是，要使商业化策略与最终用户的工作流程、报销实际情况以及当地医疗保健系统的特征相契合。

未来，成功的企业将具备以下特点：将卓越的产品与强大的服务和数据策略相结合，投资于区域营运的灵活性，并建立能够加速检验和推广的伙伴关係关係。注重模组化、互通性和以结果为导向的证据生成，将使相关人员能够把诊断创新转化为患者照护方面可衡量的改进。总之，永续成长之路取决于严谨的执行，即连结技术能力和实际市场应用。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 在资源匮乏地区采用基于智慧型手机的横向流动化验进行分散式传染病筛检
  • 将人工智慧演算法整合到照护现场血液分析仪中，用于快速评估心血管风险
  • 开发用于床边同时检测多种呼吸道病原体的多路復用微流体晶片
  • 扩大基于 CRISPR 的照护现场平台规模，用于快速检测新出现的病毒变异株
  • 用于连续血糖监测和即时糖尿病护理管理的可穿戴生物感测器贴片的应用
  • 数位健康应用程式和家庭检测服务推动了面向消费者的快速诊断试剂套件的兴起
  • 在分散式照护现场诊断网路中采用区块链技术实现安全资料共用
  • 纸基生物感测条的出现，为经济高效照护现场检测水样本中的重金属污染物提供了可能。
  • 诊断药物生产商与製药公司合作，开发个人化癌症治疗中的伴随快速检测方法

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 按产品类型照护现场和快速诊断市场

  • 消耗品
    • 试剂
    • 检测套组
  • 装置
    • 分析器
    • 领导者
  • 软体与服务
    • 资料管理软体
    • 支援服务

第九章 按技术照护现场和快速诊断市场

  • 临床化学
  • 血液学
  • 免疫检测
  • 分子诊断

第十章 按检测类型照护现场和快速诊断市场

  • 心臟标记物
  • 凝血
  • 血糖监测
  • 感染疾病
  • 怀孕和不孕症

第十一章 按最终用户照护现场和快速诊断市场

  • 门诊医疗中心
  • 诊所
  • 诊断实验室
  • 居家照护
  • 医院

第十二章 按应用程式分類的照护现场和快速诊断市场

  • 心臟护理
  • 血液凝固检验
  • 糖尿病管理
  • 感染疾病诊断
  • 肿瘤学
  • 妊娠测试

第十三章 按分销管道照护现场和快速诊断市场

  • 直销
  • 经销商
  • 电子商务平台
  • 线上零售

第十四章 按地区照护现场和快速诊断市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 按集团照护现场和快速诊断市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国照护现场与快速诊断市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Abbott Laboratories
    • Roche Diagnostics International AG
    • Siemens Healthineers AG
    • Danaher Corporation
    • Thermo Fisher Scientific Inc.
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Quidel Corporation
    • Ortho Clinical Diagnostics GmbH
    • QIAGEN NV
Product Code: MRR-742BD5183A2E

The Point of Care & Rapid Diagnostics Market is projected to grow by USD 91.21 billion at a CAGR of 7.31% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 51.85 billion
Estimated Year [2025] USD 55.61 billion
Forecast Year [2032] USD 91.21 billion
CAGR (%) 7.31%

A clear-eyed orientation to how rapid diagnostics are decentralizing testing workflows and redefining clinical decision timelines across care settings

Point of care and rapid diagnostics are reshaping clinical workflows by delivering actionable results closer to patients and accelerating clinical decision cycles. Advances in reagent chemistry, miniaturized analyzers, robust readers, and data management software are enabling decentralized testing across ambulatory care centers, clinics, home care settings, and hospitals. As devices become easier to operate and connectivity improves, clinicians are better positioned to intervene earlier and to triage care more effectively, which in turn alters patient pathways and resource allocation.

Furthermore, as stakeholders increasingly prioritize value-based outcomes, diagnostics that deliver rapid, reliable, and actionable data are gaining practical priority. Laboratories and diagnostic networks are balancing central testing capacity with point of care capabilities to maintain quality while improving speed. Meanwhile, manufacturers are investing in integrated software and support services to ensure interoperability and to reduce total cost of ownership across installed bases. This intersection of technological progress, shifting care models, and rising expectations for timely results is creating a dynamic environment where clinical benefits, reimbursement pathways, and commercial execution must align for success

Transformative shifts in market dynamics driven by technological convergence, regulatory evolution, and changing care delivery models

The landscape is experiencing several converging drivers that are transforming where and how diagnostic testing occurs. Technological progress in molecular diagnostics, immunoassays, and compact clinical chemistry platforms is enabling higher analytical performance in smaller footprints. At the same time, data management software is moving from siloed data capture to integrated solutions that facilitate interoperability with electronic health records and telehealth platforms. Regulatory agencies are also adapting pathways to better accommodate novel point of care technologies, which reduces time to clinical adoption when manufacturers can meet quality and validation expectations.

Concurrently, the shift toward outpatient care and home-based monitoring is prompting manufacturers to re-evaluate form factors, ease of use, and channel strategies. Distribution channels that include direct sales, distributors, e-commerce platforms, and online retail are being optimized to reach new end users while maintaining post-market support through enhanced service models. As stakeholders adapt, market participants that invest in modular instrument architectures, scalable reagent systems, and cloud-enabled analytics will be better positioned to capture demand across cardiac care, diabetes management, infectious disease diagnostics, and oncology applications. In short, the next phase will reward cross-disciplinary integration that connects hardware, consumables, and software into user-centric solutions

Analysis of cumulative impacts from recent United States tariff actions on supply chains, procurement strategies, and innovation within the diagnostics ecosystem

Tariff policy shifts have introduced measurable friction into global supply chains for diagnostics components, reagents, and finished instruments. Manufacturers that rely on cross-border sourcing for analyzers, readers, reagents, or critical electronic components have adjusted supplier portfolios and production footprints to mitigate exposure. This rebalancing has driven near-term cost management activity and strategic sourcing efforts, with procurement teams focusing on supplier diversification and contractual flexibility to absorb cost volatility and logistical delays.

In addition, tariffs have influenced decisions about local assembly and regional manufacturing presence as companies evaluate the tradeoffs between incremental production costs and the benefits of supply resilience. For purchasers in hospitals, clinics, and diagnostic laboratories, procurement cycles are lengthening as stakeholders seek clarity around landed costs and service agreements. Meanwhile, suppliers are accelerating investments in automation and quality control to offset higher per-unit costs and to preserve margins without compromising product performance.

Looking forward, firms that proactively redesign sourcing strategies, prioritize modularity in instrument design to leverage interchangeable components, and strengthen strategic partnerships across distribution channels will reduce tariff-driven exposure. Equally important, regulatory and reimbursement stakeholders will need to consider the cumulative effect of these commercial responses on access and on the pace of innovation in high-impact areas such as molecular and immunoassay testing

Actionable segmentation insights that highlight demand drivers and commercialization priorities across product categories, technologies, and end-user settings

A product-type lens reveals distinct imperatives for consumables, instruments, and software & services. Consumables, including reagents and test kits, emphasize lot-to-lot consistency, shelf-life stability, and supply-chain continuity; instruments, spanning analyzers and readers, prioritize robustness, uptime, and ease of maintenance; while data management software and support services require secure interoperability, analytics capability, and scalable service contracts. Technology segmentation across clinical chemistry, hematology, immunoassay, and molecular diagnostics highlights divergent validation pathways and user expectations, with molecular approaches commanding particular attention for pathogen detection and high-sensitivity assays.

When examining test types such as cardiac markers, coagulation, glucose monitoring, infectious diseases, and pregnancy & fertility panels, commercialization strategies must align with clinical pathways and reimbursement realities to support clinician adoption. End-user segmentation emphasizes that ambulatory care centers and clinics prioritize rapid turnaround and portability, diagnostic laboratories focus on throughput and centralization, home care settings demand simplicity and remote data integration, and hospitals require integration into complex IT ecosystems. Application-focused strategies for cardiac care, coagulation testing, diabetes management, infectious disease diagnostics, oncology, and pregnancy testing must balance analytical rigor with user-centric design. Finally, distribution channel choices-direct sales, distributors, e-commerce platforms, and online retail-shape pricing, warranty models, and post-sale support, making channel strategy a core determinant of market reach and customer satisfaction

Regional dynamics and practical considerations for deploying point of care solutions across diverse healthcare systems and market environments

The Americas exhibit a heterogeneous mix of centralized laboratory networks and expanding point of care deployment in outpatient and home settings, which creates opportunities for technologies that integrate with electronic health records and enable remote monitoring. Across Europe, Middle East & Africa, differences in reimbursement structures and infrastructure maturity drive variable adoption curves; in some markets rapid diagnostics are being adopted as part of national screening and public health initiatives, whereas others emphasize centralized laboratory consolidation. In Asia-Pacific, growth is supported by investments in decentralized care pathways, rising chronic disease management programs, and a competitive manufacturing base that accelerates product localization.

Across all regions, regulatory alignment, reimbursement clarity, and supply chain resilience remain critical determinants of successful commercialization. Localized training and support models, tailored pricing strategies, and partnerships with clinical networks facilitate adoption. Moreover, interoperability with regional health information exchanges and telemedicine platforms enhances the clinical value proposition. Ultimately, companies that marry global best practices with local execution capabilities will unlock meaningful adoption across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Competitive landscape insights focusing on product portfolios, service propositions, and partnership models that shape market positioning

Leading companies in the point of care and rapid diagnostics space are differentiating through integrated solutions that pair modular analyzers with consumable ecosystems and cloud-enabled data platforms. Product portfolios that combine reliable reagents and adaptable test kits with instruments engineered for uptime create compelling value for diagnostic laboratories and hospital systems. Equally, organizations that invest in data management software and comprehensive support services reduce adoption friction by ensuring connectivity, compliance, and lifecycle serviceability.

Partnership models are shifting toward co-development agreements with clinical institutions and technology providers to accelerate validation and to generate real-world evidence. Distribution strategies that blend direct sales with distributor partnerships and digital channels are enabling broader market reach while preserving local service capabilities. Competitive advantage increasingly depends on the ability to demonstrate outcomes, to reduce total cost of ownership, and to provide integrated post-sale support. Companies that align product development with clinician workflows and that leverage partnerships to deliver end-to-end solutions will maintain stronger positioning in a market where performance, service excellence, and interoperability determine buyer preference

Practical and prioritized recommendations for industry leaders to accelerate adoption, protect margins, and future-proof their operations

Manufacturers should prioritize modular instrument architectures that allow for component substitution and simplify servicing, thereby reducing the operational impact of supply chain disruptions. In parallel, investing in data management software that supports interoperability and remote diagnostics will enhance clinician trust and enable service-based revenue models. From a commercial perspective, aligning pricing and reimbursement strategies with clinical outcomes and total cost of care will facilitate adoption in both hospital networks and ambulatory channels.

Operationally, companies must strengthen multi-sourcing strategies, consider regional manufacturing partnerships to mitigate tariff exposure, and implement agile inventory management practices. Strategic collaborations with clinical sites for early validation and real-world evidence generation will accelerate payer engagement and clinician uptake. Finally, forging flexible distribution approaches that combine direct sales, careful distributor selection, and digital commerce will expand reach while preserving post-sale service standards. Taken together, these actions will help leaders maximize impact, sustain margins, and remain nimble in an environment characterized by rapid technological change and evolving care delivery models

Rigorous research methodology and data synthesis approach used to produce reproducible insights and validate conclusions

The research process integrated qualitative and quantitative evidence streams to create a robust understanding of market dynamics. Primary inputs included structured interviews with clinical decision-makers, procurement leaders, and product managers across hospitals, diagnostic laboratories, ambulatory care centers, and home care providers. Secondary sources encompassed peer-reviewed literature, regulatory guidance, and company disclosures to triangulate technology trends, validation requirements, and commercial models.

Data synthesis applied thematic analysis to capture common adoption barriers and enablement factors, while comparative case studies highlighted successful deployment models across different regions. Throughout, methodological safeguards ensured that conclusions relied on validated expert perspectives and documented performance characteristics rather than speculative forecasts. The approach prioritized transparency in assumptions and documented limitations to allow readers to interpret findings within the appropriate operational context. This methodological rigor produces actionable insights that are reproducible and applicable to strategy formulation, product development, and commercial planning

Concluding perspectives that synthesize strategic implications and reinforce priorities for decision-makers navigating the point of care diagnostics landscape

The rapid diagnostics ecosystem is at an inflection point where technological advances intersect with shifting care delivery models and evolving policy environments. Decision-makers must prioritize integration across hardware, consumables, and software to deliver consistent clinical value while maintaining operational resilience in the face of supply chain and trade dynamics. Equally important is the alignment of commercialization strategies with end-user workflows, reimbursement realities, and regional healthcare system characteristics.

Looking ahead, success will favor organizations that combine product excellence with robust service and data strategies, that invest in regional operational flexibility, and that cultivate partnerships to accelerate validation and adoption. By concentrating on modularity, interoperability, and outcomes-driven evidence generation, stakeholders can translate diagnostic innovations into measurable improvements in patient care. In sum, the pathway to sustainable growth rests on disciplined execution that bridges technical capability with pragmatic market implementation

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of smartphone-based lateral flow assays for decentralized infectious disease screening in low-resource settings
  • 5.2. Integration of AI algorithms in point-of-care blood analyzers for rapid cardiovascular risk assessment
  • 5.3. Development of multiplexed microfluidic cartridges enabling simultaneous detection of multiple respiratory pathogens at bedside
  • 5.4. Expansion of CRISPR-based point-of-care diagnostic platforms for rapid detection of emerging viral variants
  • 5.5. Implementation of wearable biosensor patches for continuous glucose monitoring and real-time diabetic care management
  • 5.6. Rise of direct-to-consumer rapid diagnostic kits facilitated by digital health apps and home testing services
  • 5.7. Adoption of blockchain technology for secure data sharing in decentralized point-of-care diagnostic networks
  • 5.8. Emergence of paper-based biosensing strips for cost-effective point-of-care detection of heavy metal contaminants in water samples
  • 5.9. Collaboration between diagnostic manufacturers and pharmaceutical companies for companion rapid tests in personalized oncology care

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Point of Care & Rapid Diagnostics Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Reagents
    • 8.1.2. Test Kits
  • 8.2. Instruments
    • 8.2.1. Analyzers
    • 8.2.2. Readers
  • 8.3. Software & Services
    • 8.3.1. Data Management Software
    • 8.3.2. Support Services

9. Point of Care & Rapid Diagnostics Market, by Technology

  • 9.1. Clinical Chemistry
  • 9.2. Hematology
  • 9.3. Immunoassay
  • 9.4. Molecular Diagnostics

10. Point of Care & Rapid Diagnostics Market, by Test Type

  • 10.1. Cardiac Markers
  • 10.2. Coagulation
  • 10.3. Glucose Monitoring
  • 10.4. Infectious Diseases
  • 10.5. Pregnancy & Fertility

11. Point of Care & Rapid Diagnostics Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Clinics
  • 11.3. Diagnostic Laboratories
  • 11.4. Home Care Settings
  • 11.5. Hospitals

12. Point of Care & Rapid Diagnostics Market, by Application

  • 12.1. Cardiac Care
  • 12.2. Coagulation Testing
  • 12.3. Diabetes Management
  • 12.4. Infectious Disease Diagnostics
  • 12.5. Oncology
  • 12.6. Pregnancy Testing

13. Point of Care & Rapid Diagnostics Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. E-Commerce Platforms
  • 13.4. Online Retail

14. Point of Care & Rapid Diagnostics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Point of Care & Rapid Diagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Point of Care & Rapid Diagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Abbott Laboratories
    • 17.3.2. Roche Diagnostics International AG
    • 17.3.3. Siemens Healthineers AG
    • 17.3.4. Danaher Corporation
    • 17.3.5. Thermo Fisher Scientific Inc.
    • 17.3.6. Becton, Dickinson and Company
    • 17.3.7. bioMerieux SA
    • 17.3.8. Quidel Corporation
    • 17.3.9. Ortho Clinical Diagnostics GmbH
    • 17.3.10. QIAGEN N.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. POINT OF CARE & RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. POINT OF CARE & RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. POINT OF CARE & RAPID DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032